Literature DB >> 18270997

Catechol-O-methyltransferase (COMT) gene variants: possible association of the Val158Met variant with opiate addiction in Hispanic women.

Bronson E Oosterhuis1, K Steven LaForge, Dmitri Proudnikov, Ann Ho, David A Nielsen, Robert Gianotti, Sandra Barral, Derek Gordon, Suzanne M Leal, Jurg Ott, Mary Jeanne Kreek.   

Abstract

Catechol-O-methyltransferase (COMT) catalyzes the breakdown of catechol neurotransmitters, including dopamine, which plays a prominent role in drug reward. A common single nucleotide polymorphism (SNP), G472A, codes for a Val158Met substitution and results in a fourfold down regulation of enzyme activity. We sequenced exon IV of COMT gene in search for novel polymorphisms and then genotyped four out of five identified by direct sequencing, using TaqMan assay on 266 opioid-dependent and 173 control subjects. Genotype frequencies of the G472A SNP varied significantly (P = 0.029) among the three main ethnic/cultural groups (Caucasians, Hispanics, and African Americans). Using a genotype test, we found a trend to point-wise association (P = 0.053) of the G472A SNP in Hispanic subjects with opiate addiction. Further analysis of G472A genotypes in Hispanic subjects with data stratified by gender identified a point-wise significant (P = 0.049) association of G/A and A/A genotypes with opiate addiction in women, but not men. These point-wise significant results are not significant experiment-wise (at P < 0.05) after correction for multiple testing. No significant association was found with haplotypes of the three most common SNPs. Linkage disequilibrium patterns were similar for the three ethnic/cultural groups. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270997      PMCID: PMC2909109          DOI: 10.1002/ajmg.b.30716

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  52 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Genetic Data Analysis. Methods for Discrete Population Genetic Data. Bruce S. Weir. Sinauer, Sunderland, MA, 1990. xiv, 377 pp., illus. $48; paper, $27.

Authors:  R R Hudson
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

3.  Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism.

Authors:  J Tiihonen; T Hallikainen; H Lachman; T Saito; J Volavka; J Kauhanen; J T Salonen; O P Ryynänen; M Koulu; M K Karvonen; T Pohjalainen; E Syvälahti; J Hietala
Journal:  Mol Psychiatry       Date:  1999-05       Impact factor: 15.992

Review 4.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

5.  Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study.

Authors:  R Horowitz; M Kotler; E Shufman; S Aharoni; I Kremer; H Cohen; R P Ebstein
Journal:  Am J Med Genet       Date:  2000-10-09

6.  Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.

Authors:  M Karayiorgou; C Sobin; M L Blundell; B L Galke; L Malinova; P Goldberg; J Ott; J A Gogos
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

7.  Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study.

Authors:  I Massat; D Souery; J Del-Favero; M Nothen; D Blackwood; W Muir; R Kaneva; A Serretti; C Lorenzi; M Rietschel; V Milanova; G N Papadimitriou; D Dikeos; C Van Broekhoven; J Mendlewicz
Journal:  Mol Psychiatry       Date:  2005-06       Impact factor: 15.992

8.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

9.  Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Synapse       Date:  2003-12-01       Impact factor: 2.562

10.  The association between panic disorder and the L/L genotype of catechol-O-methyltransferase.

Authors:  Jong-Min Woo; Kyung-Sik Yoon; Young-Hee Choi; Kang-Sub Oh; Young-Sik Lee; Bum-Hee Yu
Journal:  J Psychiatr Res       Date:  2004 Jul-Aug       Impact factor: 4.791

View more
  10 in total

Review 1.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

2.  HIV serostatus differs by catechol-O-methyltransferase Val158Met genotype.

Authors:  Erin E Sundermann; Jeffrey R Bishop; Leah H Rubin; Bradley Aouizerat; Tracey E Wilson; Kathleen M Weber; Mardge Cohen; Elizabeth Golub; Kathryn Anastos; Chenglong Liu; Howard Crystal; Celeste L Pearce; Pauline M Maki
Journal:  AIDS       Date:  2013-07-17       Impact factor: 4.177

Review 3.  Genetics of opiate addiction.

Authors:  Brian Reed; Eduardo R Butelman; Vadim Yuferov; Matthew Randesi; Mary Jeanne Kreek
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

4.  OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.

Authors:  Kwo Wei David Ho; Margaret R Wallace; Roland Staud; Roger B Fillingim
Journal:  Pharmacogenomics J       Date:  2019-12-06       Impact factor: 3.550

5.  Pharmacotherapy in the treatment of addiction: methadone.

Authors:  Mary Jeanne Kreek; Lisa Borg; Elizabeth Ducat; Brenda Ray
Journal:  J Addict Dis       Date:  2010-04

Review 6.  Common and specific liability to addiction: approaches to association studies of opioid addiction.

Authors:  David A Nielsen; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2012-04-27       Impact factor: 4.492

7.  Proline affects brain function in 22q11DS children with the low activity COMT 158 allele.

Authors:  Jacob A S Vorstman; Bruce I Turetsky; Monique E J Sijmens-Morcus; Monique G de Sain; Bert Dorland; Mirjam Sprong; Eric F Rappaport; Frits A Beemer; Beverly S Emanuel; René S Kahn; Herman van Engeland; Chantal Kemner
Journal:  Neuropsychopharmacology       Date:  2008-09-03       Impact factor: 7.853

8.  Assessing the contribution of opioid- and dopamine-related genetic polymorphisms to the abuse liability of oxycodone.

Authors:  Jermaine D Jones; Mudassir Mumtaz; Jeanne M Manubay; Shanthi Mogali; Elliana Sherwin; Suky Martinez; Sandra D Comer
Journal:  Pharmacol Biochem Behav       Date:  2019-09-04       Impact factor: 3.533

9.  A novel SNP in COMT is associated with alcohol dependence but not opiate or nicotine dependence: a case control study.

Authors:  Joanne Voisey; Christopher D Swagell; Ian P Hughes; Bruce R Lawford; Ross M D Young; C Phillip Morris
Journal:  Behav Brain Funct       Date:  2011-12-31       Impact factor: 3.759

10.  Catechol-O-methyltransferase and dopamine receptor D4 gene variants: Possible association with substance abuse in Bangladeshi male.

Authors:  Jahanara Akter Sonia; Tohfa Kabir; M M Towhidul Islam; Yearul Kabir
Journal:  PLoS One       Date:  2021-02-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.